期刊文献+

格拉斯哥预后评分和中性粒细胞/淋巴细胞比值在骨肉瘤预后评估中的作用 被引量:6

Role of systemic inflammatory response in evaluating the prognosis of patients with osteosarcoma
下载PDF
导出
摘要 目的探讨全身炎症反应标志物格拉斯哥预后评分(m GPS)和中性粒细胞/淋巴细胞比值(NLR)在骨肉瘤预后评估中的作用。方法回顾性收集从2008年1月1日至2016年12月31日在我院经组织学病理诊断为骨肉瘤的103例患者资料。分析NLR和mGPS在各临床病理特征组间有无显著差异。Cox回归单因素和多因素分析研究独立预后因子。描绘列线图并采用c-index评价预测精确度。结果 NLR在临床病理特征各组间均无显著差异,性别(P=0.039)、年龄(P=0.000)、肿瘤部位(P=0.030)与mGPS显著相关。肿瘤部位(P=0.023)、初诊时有无转移(P=0.000)、NLR(P=0.011)和mGPS(P=0.007)是骨肉瘤患者总生存期(OS)的独立预后因子,而初诊时有无转移(P=0.029)、NLR(P=0.032)和mGPS(P=0.014)是无事件生存期(EFS)的独立风险因子。列线图显示这个预后预测模型对骨肉瘤的预测准确度较好,OS和EFS的c-index值分别为0.689和0.685。结论 mGPS和NLR均可有效预测骨肉瘤患者的预后。两者在骨肉瘤预后评估中应用价值差距不大。 Objective To investigate the role of the modified Glasgow prognostic score(mGPS)and neutro-phil lymphocyte ratio(NLR)in evaluating the prognosis of patients with osteosarcoma.Mehtods One hundred and three patients with osteosarcoma diagnosed by histology in our hospital from January 1,2008 to December 31,2016 were enrolled in this retrospective study.The values of NLR and mGPS catagorized by different clinical param-eters were compaired.Univariate and multivariate analyses were performed to evaluate the overall survival(OS)and event-free survival(EFS).Nomograms were established to predict the prognosis of osteosarcoma.Results There was no difference of NLR level in paients catagorized by different clinicopathological features.However,there were significant correlations between sex(P=0.039),age(P=0.000),tumor site(P=0.030)and mGPS.In multivariate analysis,tumor site(P=0.023),metastasis(P=0.000),NLR(P=0.011)and mGPS(P=0.007)were independent prognostic factors for OS,while metastasis(P=0.029),NLR(P=0.032)and mGPS(P=0.014)were independent predictors for EFS.The Harrell′s c-index for OS and EFS prediction was 0.689 and 0.685,respectively.Thus the nomogram based on NLR and mGPS could be used as an accurate prognostic prediction for patients with osteosarcoma.Conclusion mGPS and NLR have similar clinical values and both of them can accu-rately predict the prognosis of osteosarcoma.
作者 黄振华 杨晨 罗宇玲 邓琼 戎晓祥 HUANG Zhenhua;YANG Chen;LUO Yuling;DENG Qiong;RONG Xiaoxiang(Department of Oncology,Nanfang Hospi.tal,Southern Medical University,Guangzhou 510515,China)
出处 《实用医学杂志》 CAS 北大核心 2018年第20期3410-3414,共5页 The Journal of Practical Medicine
基金 大学生创新创业训练计划项目(编号:201712121041)
关键词 骨肉瘤 总生存期 无事件生存期 预后因子 格拉斯哥预后评分 中性粒细胞/淋巴细胞比值 osteosarcoma overall survival event.free survival prognostic factor modified Glasgow prognostic score neutrophil lymphocyte ratio
  • 相关文献

参考文献2

二级参考文献12

  • 1Zhang Y, Wang L, Liu Y, et al. Preoperative neutrophil- lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery [J]. Int J Gynecol Cancer, 2014,24(7):1319- 1325.
  • 2Mizunuma M, Yokoyama Y. The pretreatment neutrophil-to- lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer [ J ]. Int J Clin Dncol, 2015,20 ( 5 ) : 989 -996.
  • 3Warschkow R, Tarantino I, Ukegjini K, et al. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery [J]. Langenbecks Arch Surg, 2012,397 (5): 727-736.
  • 4Dutta S, Going JJ, Crumley AB, et al. The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma [J]. Br J Cancer, 2012,106(4) :702-710.
  • 5Fridlender ZG, Sun J, Mishalian I, et al. Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils [J]. PLoS One, 2012,7(2):e31524.
  • 6Lee YY, Choi CH, Kim HJ, et al. Pretreatment neutrophil: lymphocyte ratio as a prognostic factor in cervical carcinoma [J ]. Anticancer Res, 2012,32(4) : 1555-1561.
  • 7李健,叶定伟,姚旭东,张世林,戴波,张海梁,沈益君,朱耀,施国海,朱一平,马春光,秦晓健,林国文,肖文军.术前血小板/淋巴细胞比值判断上尿路尿路上皮癌临床分期及预后的价值[J].中国癌症杂志,2013,23(6):457-461. 被引量:13
  • 8周文毓,陈金婵,惠宁.治疗前血小板和淋巴细胞比值与宫颈癌新辅助化疗疗效及预后的相关性[J].中国肿瘤临床,2014,41(16):1045-1048. 被引量:15
  • 9山长平,夏重升,杨娅,王军业,苏修军.术前外周血血小板与淋巴细胞比值对非小细胞肺癌患者预后的影响[J].中国肿瘤临床,2014,41(21):1374-1378. 被引量:15
  • 10蔡东焱,吴小红,洪婷婷,张颖,茆勇,华东.结直肠癌患者围手术期血小板和血小板/淋巴细胞比值变化及其与预后的关系[J].中华实验外科杂志,2014,31(12):2876-2878. 被引量:4

共引文献21

同被引文献56

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部